1.22
price down icon4.69%   -0.06
after-market 시간 외 거래: 1.18 -0.04 -3.28%
loading

Novabay Pharmaceuticals Inc 주식(NBY)의 최신 뉴스

pulisher
Mar 18, 2026

Taxes of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Mar 18, 2026
pulisher
Mar 17, 2026

Total assets of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Preferred dividends of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 17, 2026
pulisher
Mar 15, 2026

NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance By Investing.com - Investing.com Nigeria

Mar 15, 2026
pulisher
Mar 15, 2026

Book value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 15, 2026
pulisher
Mar 15, 2026

Total debt per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 15, 2026
pulisher
Mar 15, 2026

Revenue per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 15, 2026
pulisher
Mar 14, 2026

Gross profit of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Mar 14, 2026
pulisher
Mar 13, 2026

NBY Stock Price, Quote & Chart | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill

Mar 13, 2026
pulisher
Mar 12, 2026

NovaBay Pharmaceuticals Approves Issuance of 837 Million Shares and 2026 Equity Incentive Plan in Shareholder Vote - Minichart

Mar 12, 2026
pulisher
Mar 12, 2026

NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance - Investing.com UK

Mar 12, 2026
pulisher
Mar 12, 2026

NovaBay Pharma Expands Share Capital and Governance Flexibility - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

NovaBay (NYSE: NBY) OKs 5B share authorization and charter changes - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Novabay Pharmaceuticals: All six proposals, including share issuances and governance amendments, were approved - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Novabay Pharmaceuticals: All six proposals, including share issuances and governance changes, were approved - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

NOVABAY PHARMACEUTICALS INC Financial Disclosures & Filings - TradingView

Mar 12, 2026
pulisher
Mar 11, 2026

Poplar Point cuts NovaBay (NBY) ownership below 5% reporting level - Stock Titan

Mar 11, 2026
pulisher
Mar 07, 2026

Dividend Watch: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARPortfolio Update Report & Stock Market Timing Techniques - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Aug Decliners: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARTrade Entry Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill

Mar 04, 2026
pulisher
Mar 03, 2026

Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn

Mar 03, 2026
pulisher
Mar 02, 2026

Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 02, 2026
pulisher
Feb 28, 2026

NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 28, 2026
pulisher
Feb 26, 2026

Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView

Feb 26, 2026
pulisher
Feb 25, 2026

Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Earnings and Revenue – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBIT of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating income of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Average basic shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total operating expenses of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net debt of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total liabilities & shareholders' equities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Cost of goods sold of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total equity of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Quick ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Cash Flow – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Income Statement – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total debt per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Balance Sheet – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 24, 2026

Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Financial Statements – MUN:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Dividends – MUN:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

CapEx per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Gross profit of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 24, 2026
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):